top of page

STI Directory Leader

Geistlich Pharma AG

avatar-1577909_960_720.png

Geistlich Pharma AG, based in Wolhusen, Lucerne, is a 171 years old Swiss family owned company that develops and manufactures regenerative medical products. More than 700 employees work at the headquarters in Wolhusen, in Root and in 12 subsidiaries. Geistlich Pharma focuses on dental regenerative treatments, sports medicine and wound care solutions.

Year of listing

Industry

2022

Pharmaceuticals & Supplies

Luzern

Region

Size

250-4'999

Pledges

Direct contribution to SDGs

Type of Pledge

Goal 1

By 2025, we ensure that over 500 dentists worldwide annually follow ongoing high-quality dental education in regenerative dentistry, which we offer on a free basis, compared to the industry standard of CHF 70 / hour of training*. 


* Virtual, hybrid or in-person ongoing education, accessible to dentists from developing countries. Regenerative dentistry relating to bone and soft mouth tissue regeneration to improve health and allow placement of implants for a better patient treatment globally, accepted by leading universities in Europe and USA.

press to zoom
press to zoom
press to zoom
press to zoom

Core business

Goal 2

By 2026, at least 35 % of women are represented in our senior management functions compared to 25 % in 2022, with the goal of gender parity by 2030*. 


* Senior management functions meaning Executive Leadership Team, Department Heads and Group Heads.

press to zoom
press to zoom

Internal operations

Goal 3

By 2030, our main production site in Wolhusen is carbon neutral (Scopes 1 & 2) and we commit to the Science Based Targets initiative (SBTi)*. 


* Increasing the share of our on-site produced electricity from renewable sources to 50 %, using less than 1 % of current fossil fuels to generate heat or cooling, thanks to climate-neutral and in-house produced electricity from our adjacent river and solar panels.

press to zoom
press to zoom

Internal operations

Scope of Pledges: 

Geistlich Pharma AG operates in Switzerland and abroad through several subsidiaries. The pledges taken within the STI framework relate to the sustainability policy applying to all Geistlich Pharma AG operations carried out in Switzerland and abroad. The company is therefore accountable for their implementation within the limits of its scope of activity.

Note: By 2023 systematically indicates the end of the year, meaning: By the end of 2023 (unless otherwise defined, such as fiscal year) 

Other Commitments

bottom of page